NHS: Doctor treats four generations of same Medway family
The family have all received care from Professor Kypros Nicolaides at King’s College Hospital.
Related Articles
Decipher® in mHSPC: Guiding Risk Assessment and Treatment Intensification – Gerhardt Attard
Nicholas James and Gerhardt Attard discuss findings from the STAMPEDE trial, focusing on molecular profiling of prostate cancer tumors. They explore the use of the…
Optimizing Next-Generation Sequencing in Urothelial Cancer: Expert Consensus Recommendations – Andrea Necchi
Ashish Kamat engages with Andrea Necchi about the use of next-generation sequencing (NGS) in urothelial carcinoma. Dr. Necchi highlights consensus recommendations from a recent retreat,…
Advancing Radiopharmaceuticals: Isotopes, Targets, and Challenges – Germo Gericke
Oliver Sartor discusses radiopharmaceuticals with Germo Gericke. Dr. Gericke emphasizes the potential of targeted radioligand therapies, particularly for advanced cancers. He explores various isotopes, including…
FDA News
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care…
PI-CAI Challenge: AI vs Radiologists in Prostate Cancer MRI Detection, Journal Club – Rashid Sayyid & Zachary Klaassen
Rashid Sayyid and Zach Klaassen discuss the PI-CAI Challenge, an international study comparing artificial intelligence (AI) to radiologists in prostate cancer detection using MRI. The…
Combining Nuclear Medicine and Immunotherapy for Enhanced Cancer Treatment – Chris Behrenbruch
Oliver Sartor interviews Chris Behrenbruch about radiopharmaceuticals in cancer treatment. Dr. Behrenbruch discusses his passion for nuclear medicine, emphasizing its multidisciplinary nature and potential for…
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
Kim, Sindher, Huffaker spoke with HCPLive about some of the year’s most important developments in the food allergy space, namely the approvals of omalizumab and…
AI is trained to spot warning signs in blood tests
AI can spot patterns in the data from blood tests that can give an early warning of disease.
AI-Powered Prostate Cancer Grading Predicts Active Surveillance Outcomes – Cornelia Ding
Andrea Miyahira interviews Cornelia (Chien-Kuang) Ding about her study on predicting prostate cancer grade reclassification using a deep learning-based grading algorithm. Dr. Ding discusses their…